AstraZeneca's Oral GLP-1 Pill To Help Reduce Weight And Lower Blood Sugar, Study Finds

AstraZeneca's Oral GLP-1 Pill Helps Reduce Weight And Lower Blood Sugar, Study Finds

Credit: AI Generated Image

Text

Updated Jun 10, 2026 | 09:00 PM IST

SummaryAstraZeneca’s oral GLP-1 pill, elecoglipron, lowered blood sugar and reduced body weight by 10.5% in a Phase 2b diabetes trial, highlighting growing potential for injection-free diabetes and obesity treatments.

End of Article